Tobramycin-Silver Nanocomposite: A New Trend of Antimicrobials against Resistant Strains

Helal, Hala S; El-Din, Taher A. Salah; Ali, Arwa; Hamouda, Hayam H.; Zedan, Hamdallah

doi:10.9790/3008-09615461

Cited by 2 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Accordingly, Helal et al . () demonstrated tobramycin‐silver nanocomposite as a novel antimicrobial agent. They studied the antimicrobial activity against different antibiotic resistant micro‐organisms such as Staph.…”

Section: Role Of Various Nanomaterials For the Management Of Infectionsmentioning

confidence: 99%

See 1 more Smart Citation

Nanotechnology based anti-infectives to fight microbial intrusions

et al. 2016

View full text Add to dashboard Cite

SummaryWith the rise in human population across the globe especially in developing countries, the incidence of microbial infections are increasing with greater pace. On the other hand, available medication and therapies are found to be insufficient for the complete cure of such microbial infections due to the development of resistance against various antibiotics. Therefore, to cope up the menace of microbial infections and drug resistance, there is demand for new and compelling technology, which has the ability to impede these problems. Many research groups worldwide are finding a ray of hope in nanomaterials owing to their unique properties. In the present review we have discussed the reasons behind the development of new materials based on nanotechnology. It is mainly focused on pioneering studies on application of nanomaterials like carbon nanotube, fullerene, dendrimers, nanocomposite and metal nanoparticles in combating dreadful pathogens. Moreover, the concerns about their toxicity have also been discussed.

show abstract

Section: Role Of Various Nanomaterials For the Management Of Infectionsmentioning

confidence: 99%

“…aeruginosa (MTCC 424) and Salmonella enterica (MTCC 1253) (Potara et al 2011;Kaur and Thakur 2013). Accordingly, Helal et al (2014) demonstrated tobramycin-silver nanocomposite as a novel antimicrobial agent. They studied the antimicrobial activity against different antibiotic resistant micro-organisms such as Staph.…”

Section: Nanocompositesmentioning

confidence: 99%